Portfolio company
Shape Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
Alia Therapeutics
The company develops gene editing medicines for patients with genetic diseases.
Armatus
The company develops vectorized RNAi therapeutics to treat genetic neurological and neuromuscular diseases for patients with rare conditions.
Replay Therapeutics
This biotech company develops genome writing and delivery platforms to provide genetic medicines for patients with rare skin, eye and haematological diseases.
DTX Pharma
This biotechnology firm develops RNA-based therapeutics for patients with rare neuromuscular and central nervous system disorders using a proprietary fatty acid delivery platform.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Coave Therapeutics
The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.
Scenic Biotech
This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.